562 related articles for article (PubMed ID: 22356303)
1. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
Kshirsagar SJ; Bhalekar MR; Mohapatra SK
Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
[TBL] [Abstract][Full Text] [Related]
2. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.
Ubaidulla U; Reddy MV; Ruckmani K; Ahmad FJ; Khar RK
AAPS PharmSciTech; 2007 Jan; 8(1):2. PubMed ID: 17408218
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of carvedilol in rats: probing the percutaneous permeation enhancement mechanism of soybean extract-chitosan mixture.
Sapra B; Jain S; Tiwary AK
Drug Dev Ind Pharm; 2009 Oct; 35(10):1230-41. PubMed ID: 19555244
[TBL] [Abstract][Full Text] [Related]
4. Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
Agrawal SS; Aggarwal A
Contemp Clin Trials; 2010 Jul; 31(4):272-8. PubMed ID: 20382272
[TBL] [Abstract][Full Text] [Related]
5. Effect of Asparagus racemosus extract on transdermal delivery of carvedilol: a mechanistic study.
Sapra B; Jain S; Tiwary AK
AAPS PharmSciTech; 2009; 10(1):199-210. PubMed ID: 19238554
[TBL] [Abstract][Full Text] [Related]
6. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
[TBL] [Abstract][Full Text] [Related]
7. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of carvedilol transdermal patches.
Tanwar YS; Chauhan CS; Sharma A
Acta Pharm; 2007 Jun; 57(2):151-9. PubMed ID: 17507312
[TBL] [Abstract][Full Text] [Related]
9. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.
Dixit N; Kohli K; Baboota S
PDA J Pharm Sci Technol; 2008; 62(1):46-55. PubMed ID: 18402367
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
11. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
Tirunagari M; Jangala VR; Khagga M; Gannu R
Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism.
Rana P; Murthy RS
Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066
[TBL] [Abstract][Full Text] [Related]
13. Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation.
Aboud HM; Ali AA; El-Menshawe SF; Elbary AA
Drug Deliv; 2016 Sep; 23(7):2471-2481. PubMed ID: 25715807
[TBL] [Abstract][Full Text] [Related]
14. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation.
Sapra B; Jain S; Tiwary AK
Drug Deliv; 2008 Sep; 15(7):443-54. PubMed ID: 18712622
[TBL] [Abstract][Full Text] [Related]
16. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
17. A drug-in-adhesive transdermal patch for S-amlodipine free base: in vitro and in vivo characterization.
Sun Y; Fang L; Zhu M; Li W; Meng P; Li L; He Z
Int J Pharm; 2009 Dec; 382(1-2):165-71. PubMed ID: 19716871
[TBL] [Abstract][Full Text] [Related]
18. Effects of myricetin on the bioavailability of carvedilol in rats.
Lee W; Woo ER; Choi JS
Pharm Biol; 2012 Apr; 50(4):516-22. PubMed ID: 22132944
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
Aboelwafa AA; El-Setouhy DA; Elmeshad AN
AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
[TBL] [Abstract][Full Text] [Related]
20. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
